| 000 | 00871 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513191637.0 | ||
| 264 | 0 | _c19991119 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0143-5221 | ||
| 024 | 7 |
_a10.1042/cs0970343 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVallance, P | |
| 245 | 0 | 0 |
_aNitric oxide in human hypertension-up, down or unaffected? _h[electronic resource] |
| 260 |
_bClinical science (London, England : 1979) _cSep 1999 |
||
| 300 |
_a343-4 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xphysiopathology |
| 650 | 0 | 4 |
_aNitric Oxide _xphysiology |
| 650 | 0 | 4 |
_aVasodilation _xphysiology |
| 773 | 0 |
_tClinical science (London, England : 1979) _gvol. 97 _gno. 3 _gp. 343-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/cs0970343 _zAvailable from publisher's website |
| 999 |
_c10421627 _d10421627 |
||